# Intravenous Sodium Thiosulfate on Coronary Calcification in Patients on Hemodialysis

> **NCT00720772** · PHASE2 · COMPLETED · sponsor: **Ramathibodi Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Coronary Calcification
- Vascular Calcification

## Interventions

- **DRUG:** 25% intravenous (IV) sodium thiosulfate

## Key facts

- **NCT ID:** NCT00720772
- **Lead sponsor:** Ramathibodi Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2009-05
- **Final completion:** 2009-11
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2009-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00720772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00720772, "Intravenous Sodium Thiosulfate on Coronary Calcification in Patients on Hemodialysis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00720772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*